FDA Probes Hospitalizations Linked to Fake Ozempic: Report
Supplies of the legitimate medication are in short supply amid rocketing demand.

Tom Little/Reuters
Get the Cheat Sheet newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
The Food and Drug Administration has vowed to investigate after at least three Americans were reported hospitalized after taking suspected counterfeit weight loss drugs including Ozempic, according to CBS News. As of the end of September, the FDA’s Adverse Event Reporting System recorded 42 reports from around the world mentioning bogus semaglutide—the antidiabetic medication used in Novo Nordisk’s drugs Ozempic and Wegovy, both of which are also used for weight loss. Only some of the total reports specifically mentioned Ozempic, including one of the three hospitalizations that took place in the U.S. More than two dozen of the reports were considered “serious” with outcomes as extreme as fatalities. An FDA spokesperson said the agency will “investigate any report of suspect counterfeit drugs to determine the public health risks and the appropriate regulatory response.”
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation